Figure 2
Figure 2. (A) OS and DSF and (B) cumulative incidence of relapse and cumulative incidence of nonrelapse mortality rates among patients with acute promyelocytic leukemia treated in the IC-APL study.

(A) OS and DSF and (B) cumulative incidence of relapse and cumulative incidence of nonrelapse mortality rates among patients with acute promyelocytic leukemia treated in the IC-APL study.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal